{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:35:41Z","timestamp":1793450141906,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Prevention and Control of Emerging and Major Infectious Diseases National Science and Technology Major Project","award":["2025ZD01902504"],"award-info":[{"award-number":["2025ZD01902504"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2009800"],"award-info":[{"award-number":["2022YFC2009800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02512-8","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:46:12Z","timestamp":1776883572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Dual Role of Interleukin-10 in Sepsis: Research Progress and Therapeutic Prospects\u00a0"],"prefix":"10.1007","volume":"49","author":[{"given":"Xianwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"8","key":"2512_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al. 2016. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315 (8): 801\u201310.","journal-title":"JAMA"},{"issue":"10219","key":"2512_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E., S. C. Johnson, K. M. Agesa, K. A. Shackelford, D. Tsoi, and D. R. Kievlan et al. 2020. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395(10219):200\u2013211.","journal-title":"Lancet"},{"issue":"11","key":"2512_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L., A. Rhodes, W. Alhazzani, M. Antonelli, C. M. Coopersmith, and C. French et al. 2021. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine 47(11):1181\u20131247.","journal-title":"Intensive Care Medicine"},{"issue":"6","key":"2512_CR4","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone, R.C., R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, et al. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM consensus conference committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest 101 (6): 1644\u201355.","journal-title":"Chest"},{"issue":"7","key":"2512_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/00003246-199607000-00010","volume":"24","author":"RC Bone","year":"1996","unstructured":"Bone, R.C. 1996. Sir Isaac Newton, sepsis, SIRS, and CARS. Critical Care Medicine 24 (7): 1125\u20138.","journal-title":"Critical Care Medicine"},{"issue":"7","key":"2512_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll, T., F.L. van de Veerdonk, B.P. Scicluna, and M.G. Netea. 2017. The immunopathology of sepsis and potential therapeutic targets. Nature Reviews Immunology 17 (7): 407\u201320.","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"2512_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis, E. J., A. C. Aschenbrenner, M. Bauer, C. Bock, T. Calandra, and I. Gat-Viks et al. 2024. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nature Immunology 25(1):19\u201328.","journal-title":"Nature Immunology"},{"key":"2512_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577105","volume":"16","author":"X Gao","year":"2025","unstructured":"Gao, X., S. Cai, X. Li, and G. Wu. 2025. Sepsis-induced immunosuppression: Mechanisms, biomarkers and immunotherapy. Frontiers in Immunology 16: 1577105.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2512_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ccc.2016.12.001","volume":"33","author":"JC Mira","year":"2017","unstructured":"Mira, J.C., S.C. Brakenridge, L.L. Moldawer, and F.A. Moore. 2017. Persistent inflammation, immunosuppression and catabolism syndrome. Critical Care Clinics 33 (2): 245\u201358.","journal-title":"Critical Care Clinics"},{"issue":"5","key":"2512_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/TA.0000000000004087","volume":"95","author":"PA Efron","year":"2023","unstructured":"Efron, P.A., S.C. Brakenridge, A.M. Mohr, E.L. Barrios, V.E. Polcz, S. Anton, et al. 2023. The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later. The Journal of Trauma and Acute Care Surgery 95 (5): 790\u20139.","journal-title":"The Journal of Trauma and Acute Care Surgery"},{"issue":"1","key":"2512_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1471-4906(02)00009-1","volume":"24","author":"S Mocellin","year":"2003","unstructured":"Mocellin, S., M.C. Panelli, E. Wang, D. Nagorsen, and F.M. Marincola. 2003. The dual role of IL-10. Trends in Immunology 24 (1): 36\u201343.","journal-title":"Trends in Immunology"},{"key":"2512_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini, V., D.M. Noonan, E. Abdalalem, D. Goletti, C. Sansone, L. Calabrone, et al. 2023. The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Frontiers in Immunology 14: 1161067.","journal-title":"Frontiers in Immunology"},{"key":"2512_CR13","doi-asserted-by":"crossref","unstructured":"Saraiva, M., P. Vieira, and A. O\u2019Garra. 2020. Biology and therapeutic potential of interleukin-10. Journal Of Experimental Medicine ;217(1).","DOI":"10.1084\/jem.20190418"},{"issue":"12","key":"2512_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R.S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nature Reviews Immunology 13 (12): 862\u201374.","journal-title":"Nature Reviews Immunology"},{"issue":"8","key":"2512_CR15","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.4049\/jimmunol.1900637","volume":"203","author":"M Mazer","year":"2019","unstructured":"Mazer, M., J. Unsinger, A. Drewry, A. Walton, D. Osborne, T. Blood, et al. 2019. IL-10 has differential effects on the innate and adaptive immune systems of septic patients. The Journal of Immunology 203 (8): 2088\u201399.","journal-title":"The Journal of Immunology"},{"issue":"8899","key":"2512_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(94)91584-9","volume":"343","author":"A Marchant","year":"1994","unstructured":"Marchant, A., J. Devi\u00e8re, B. Byl, D. De Groote, J.L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343 (8899): 707\u20138.","journal-title":"Lancet"},{"issue":"4","key":"2512_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0883-9441(97)90030-7","volume":"12","author":"G Friedman","year":"1997","unstructured":"Friedman, G., S. Jankowski, A. Marchant, M. Goldman, R.J. Kahn, and J.L. Vincent. 1997. Blood interleukin 10 levels parallel the severity of septic shock. Journal of Critical Care 12 (4): 183\u2013187.","journal-title":"Journal of Critical Care"},{"issue":"1 Suppl","key":"2512_CR18","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/00003246-200201001-00008","volume":"30","author":"A Oberholzer","year":"2002","unstructured":"Oberholzer, A., C. Oberholzer, and L.L. Moldawer. 2002. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Critical Care Medicine 30 (1 Suppl): S58\u2013S63.","journal-title":"Critical Care Medicine"},{"issue":"3","key":"2512_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva, M., and A. O\u2019Garra. 2010. The regulation of IL-10 production by immune cells. Nature Reviews Immunology 10(3):170\u2013181.","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"2512_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/107999099313695","volume":"19","author":"RP Donnelly","year":"1999","unstructured":"Donnelly, R.P., H. Dickensheets, and D.S. Finbloom. 1999. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. Journal of Interferon & Cytokine Research 19 (6): 563\u201373.","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"2512_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8433","author":"RA Saxton","year":"2021","unstructured":"Saxton, R.A., N. Tsutsumi, L.L. Su, G.C. Abhiraman, K. Mohan, L.T. Henneberg, et al. 2021. Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10. Science. https:\/\/doi.org\/10.1126\/science.abc8433.","journal-title":"Science"},{"issue":"24","key":"2512_CR22","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.1111\/febs.16207","volume":"289","author":"RA Saxton","year":"2021","unstructured":"Saxton, R.A., and K.C. Garcia. 2021. Cryo-EM structure of the IL-10 receptor complex provides a blueprint for ligand engineering. FEBS Journal 289 (24): 8032\u20136.","journal-title":"FEBS Journal"},{"issue":"3","key":"2512_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4049\/jimmunol.155.3.1079","volume":"155","author":"DS Finbloom","year":"1995","unstructured":"Finbloom, D.S., and K.D. Winestock. 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. Journal of Immunology (Baltimore, Md.\u202f: 1950) 155 (3): 1079\u201390.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"23","key":"2512_CR24","doi-asserted-by":"publisher","first-page":"16513","DOI":"10.1074\/jbc.274.23.16513","volume":"274","author":"JK Riley","year":"1999","unstructured":"Riley, J.K., K. Takeda, S. Akira, and R.D. Schreiber. 1999. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. The Journal of Biological Chemistry 274 (23): 16513\u201321.","journal-title":"The Journal of Biological Chemistry"},{"issue":"15","key":"2512_CR25","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","volume":"167","author":"JA Kellum","year":"2007","unstructured":"Kellum, J. A., L. Kong, M. P. Fink, L. A. Weissfeld, D. M. Yealy, and M. R. Pinsky et al. 2007. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Archives Of Internal Medicine 167(15):1655\u20131663.","journal-title":"Archives Of Internal Medicine"},{"issue":"4","key":"2512_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000387","volume":"3","author":"R Yamamoto","year":"2021","unstructured":"Yamamoto, R., J. Sasaki, T. Shibusawa, T.-A. Nakada, T. Mayumi, O. Takasu, et al. 2021. Accuracy for mortality prediction with additive biomarkers including interleukin-6 in critically ill patients: A multicenter prospective observational study. Critical Care Explorations 3 (4): e0387.","journal-title":"Critical Care Explorations"},{"issue":"5","key":"2512_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/BF01540884","volume":"15","author":"A Marchant","year":"1995","unstructured":"Marchant, A., M.L. Alegre, A. Hakim, G. Pi\u00e9rard, G. Mar\u00e9caux, G. Friedman, et al. 1995. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. Journal of Clinical Immunology 15 (5): 266\u201373.","journal-title":"Journal of Clinical Immunology"},{"key":"2512_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K.W., R. de Waal Malefyt, R.L. Coffman, and A. O\u2019Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683\u2013765.","journal-title":"Annual Review of Immunology"},{"issue":"1","key":"2512_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbrc.2010.01.066","volume":"393","author":"KR Kasten","year":"2010","unstructured":"Kasten, K.R., J.T. Muenzer, and C.C. Caldwell. 2010. Neutrophils are significant producers of IL-10 during sepsis. Biochemical and Biophysical Research Communications 393 (1): 28\u201331.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2512_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2019.00327","volume":"10","author":"IT Schrijver","year":"2019","unstructured":"Schrijver, I.T., C. Th\u00e9roude, and T. Roger. 2019. Myeloid-derived suppressor cells in sepsis. Frontiers In Immunology 10: 327.","journal-title":"Frontiers In Immunology"},{"key":"2512_CR31","doi-asserted-by":"crossref","unstructured":"Zhang, W., X. Fang, C. Gao, C. Song, Y. He, and T. Zhou et al. 2022. MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets. Cytokine & Growth Factor Reviews ;69.","DOI":"10.1016\/j.cytogfr.2022.07.007"},{"issue":"6","key":"2512_CR32","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/IAI.00239-12","volume":"80","author":"L Brudecki","year":"2012","unstructured":"Brudecki, L., D.A. Ferguson, C.E. McCall, and M. El Gazzar. 2012. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infection and Immunity 80 (6): 2026\u201334.","journal-title":"Infection and Immunity"},{"issue":"3\u20134","key":"2512_CR33","first-page":"281","volume":"17","author":"AG Cuenca","year":"2010","unstructured":"Cuenca, A. G., M. J. Delano, K. M. Kelly-Scumpia, C. Moreno, P. O. Scumpia, and D. M. Laface et al. 2010. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Molecular Medicine 17(3\u20134):281\u2013292.","journal-title":"Molecular Medicine"},{"issue":"1","key":"2512_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13054-019-2628-x","volume":"23","author":"MK Hollen","year":"2019","unstructured":"Hollen, M. K., J. A. Stortz, D. Darden, M. L. Dirain, D. C. Nacionales, and R. B. Hawkins et al. 2019. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis. Critical Care 23(1):355.","journal-title":"Critical Care"},{"issue":"3","key":"2512_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","volume":"196","author":"F Uhel","year":"2017","unstructured":"Uhel, F., I. Azzaoui, M. Gr\u00e9goire, C. Pangault, J. Dulong, and J-M. Tadi\u00e9 et al. 2017. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis. American Journal Of Respiratory And Critical Care Medicine 196(3):315\u2013327.","journal-title":"American Journal Of Respiratory And Critical Care Medicine"},{"issue":"7","key":"2512_CR36","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/eji.202049141","volume":"51","author":"M De Zuani","year":"2021","unstructured":"De Zuani, M., M. Hortov\u00e1-Kohoutkov\u00e1, I. Andrej\u010dinov\u00e1, V. Tom\u00e1\u0161kov\u00e1, V. \u0160r\u00e1mek, and M. Hel\u00e1n et al. 2021. Human myeloid-derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data. European Journal Of Immunology 51(7):1785\u20131791.","journal-title":"European Journal Of Immunology"},{"issue":"4","key":"2512_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109887","volume":"37","author":"A Cardoso","year":"2021","unstructured":"Cardoso, A., A.C. Martins, A.R. Maceiras, W. Liu, I. Castro, A.G. Castro, et al. 2021. Interleukin-10 induces interferon-\u03b3-dependent emergency myelopoiesis. Cell Reports 37 (4): 109887.","journal-title":"Cell Reports"},{"key":"2512_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3389\/fimmu.2018.01511","volume":"9","author":"RB Hawkins","year":"2018","unstructured":"Hawkins, R. B., S. L. Raymond, J. A. Stortz, H. Horiguchi, S. C. Brakenridge, and A. Gardner et al. 2018. Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Frontiers In Immunology 9:1511.","journal-title":"Frontiers In Immunology"},{"key":"2512_CR39","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.smim.2019.101335","volume":"44","author":"T Bedke","year":"2019","unstructured":"Bedke, T., F. Muscate, S. Soukou, N. Gagliani, S. Huber, and Title. 2019. IL-10-producing t cells and their dual functions. Seminars in Immunology 44: 101335.","journal-title":"Seminars in Immunology"},{"issue":"9","key":"2512_CR40","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ni.1912","volume":"11","author":"L Apetoh","year":"2010","unstructured":"Apetoh, L., F.J. Quintana, C. Pot, N. Joller, S. Xiao, D. Kumar, et al. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory t cells induced by IL-27. Nature Immunology 11 (9): 854\u201361.","journal-title":"Nature Immunology"},{"issue":"2","key":"2512_CR41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4049\/jimmunol.0901233","volume":"183","author":"C Pot","year":"2009","unstructured":"Pot, C., H. Jin, A. Awasthi, S.M. Liu, C.-Y. Lai, R. Madan, et al. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. Journal of Immunology (Baltimore, Md.\u202f: 1950) 183 (2): 797\u2013801.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2512_CR42","doi-asserted-by":"publisher","first-page":"671579","DOI":"10.3389\/fimmu.2021.671579","volume":"12","author":"Y Song","year":"2021","unstructured":"Song, Y., N. Wang, L. Chen, and L. Fang. 2021. Tr1 cells as a key regulator for maintaining immune homeostasis in transplantation. Frontiers in Immunology 12: 671579.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"2512_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108433","volume":"33","author":"H Zhang","year":"2020","unstructured":"Zhang, H., A. Madi, N. Yosef, N. Chihara, A. Awasthi, C. Pot, et al. 2020. An IL-27-driven transcriptional network identifies regulators of IL-10 expression across t helper cell subsets. Cell Reports 33 (8): 108433.","journal-title":"Cell Reports"},{"key":"2512_CR44","doi-asserted-by":"crossref","unstructured":"Edwards, C. L., S. S. Ng, F. de Labastida Rivera, D. Corvino, J. A. Engel, and M. Montes de Oca et al. 2023. IL-10-producing Th1 cells possess a distinct molecular signature in malaria. J Clin Invest ;133(1).","DOI":"10.1172\/JCI153733"},{"issue":"4","key":"2512_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/ni.2006","volume":"12","author":"E Cretney","year":"2011","unstructured":"Cretney, E., A. Xin, W. Shi, M. Minnich, F. Masson, and M. Miasari et al. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nature Immunology 12(4):304\u2013311.","journal-title":"Nature Immunology"},{"issue":"9","key":"2512_CR46","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1084\/jem.20131548","volume":"211","author":"C Neumann","year":"2014","unstructured":"Neumann, C., F. Heinrich, K. Neumann, V. Junghans, M.-F. Mashreghi, J. Ahlers, et al. 2014. Role of Blimp-1 in programing Th effector cells into IL-10 producers. The Journal of Experimental Medicine 211 (9): 1807\u201319.","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"2512_CR47","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41385-022-00487-x","volume":"15","author":"J Ahlers","year":"2022","unstructured":"Ahlers, J., A. Mantei, L. Lozza, M. St\u00e4ber, F. Heinrich, and P. Bacher et al. 2022. A Notch\/STAT3-driven Blimp-1\/c-Maf-dependent molecular switch induces IL-10 expression in human CD4\u2009+\u2009T cells and is defective in Crohn\u00b4s disease patients. Mucosal Immunology 15(3):480\u2013490.","journal-title":"Mucosal Immunology"},{"issue":"5","key":"2512_CR48","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41590-024-01814-z","volume":"25","author":"M Alvarez-Martinez","year":"2024","unstructured":"Alvarez-Martinez, M., L. S. Cox, C. F. Pearson, W. J. Branchett, P. Chakravarty, and X. Wu et al. 2024. Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis. Nature Immunology 25(5):886\u2013901.","journal-title":"Nature Immunology"},{"issue":"5","key":"2512_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350730","volume":"54","author":"S Huang","year":"2024","unstructured":"Huang, S., D. Liu, L. Han, J. Deng, Z. Wang, J. Jiang, et al. 2024. Decoding the potential role of regulatory T cells in sepsis-induced immunosuppression. European Journal of Immunology 54 (5): e2350730.","journal-title":"European Journal of Immunology"},{"issue":"2","key":"2512_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxac048","volume":"35","author":"Y Matsumura","year":"2023","unstructured":"Matsumura, Y., R. Watanabe, and M. Fujimoto. 2023. Suppressive mechanisms of regulatory B cells in mice and humans. International Immunology 35(2):55\u201365.","journal-title":"International Immunology"},{"key":"2512_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri, C., and A. Bosma. 2012. Immune regulatory function of B cells. Annual Review of Immunology 30: 221\u2013241.","journal-title":"Annual Review of Immunology"},{"issue":"3","key":"2512_CR52","doi-asserted-by":"publisher","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","volume":"39","author":"MC Glass","year":"2022","unstructured":"Glass, M. C., D. R. Glass, J-P. Oliveria, B. Mbiribindi, C. O. Esquivel, and S. M. Krams et al. 2022. Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets. Cell Rep 39(3):110728.","journal-title":"Cell Rep"},{"issue":"9","key":"2512_CR53","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1111\/all.14763","volume":"76","author":"K Jansen","year":"2021","unstructured":"Jansen, K., L. Cevhertas, S. Ma, P. Satitsuksanoa, M. Akdis, and W. van de Veen. 2021. Regulatory B cells, A to z. Allergy 76 (9): 2699\u2013715.","journal-title":"Allergy"},{"issue":"4","key":"2512_CR54","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","volume":"194","author":"TF Tedder","year":"2015","unstructured":"Tedder, T.F. 2015. B10 cells: A functionally defined regulatory B cell subset. Journal of Immunology (Baltimore, Md.\u202f: 1950) 194 (4): 1395\u2013401.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2512_CR55","doi-asserted-by":"crossref","unstructured":"Piper, C. J. M., E. C. Rosser, K. Oleinika, K. Nistala, T. Krausgruber, and A. F. Rendeiro et al. 2019. Aryl hydrocarbon receptor contributes to the transcriptional program of IL-10-producing regulatory B cells. Cell Rep ;29(7).","DOI":"10.1016\/j.celrep.2019.10.018"},{"key":"2512_CR56","doi-asserted-by":"publisher","first-page":"615009","DOI":"10.3389\/fimmu.2020.615009","volume":"11","author":"A Fabri","year":"2021","unstructured":"Fabri, A., K. Kandara, R. Coudereau, M. Gossez, P. Abraham, C. Monard, et al. 2021. Characterization of circulating IL-10-producing cells in septic shock patients: A proof of concept study. Frontiers in Immunology 11: 615009.","journal-title":"Frontiers in Immunology"},{"key":"2512_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells13040357","author":"J Veh","year":"2024","unstructured":"Veh, J., C. Ludwig, H. Schrezenmeier, and B. Jahrsd\u00f6rfer. 2024. Regulatory B cells-immunopathological and prognostic potential in humans. Cells. https:\/\/doi.org\/10.3390\/cells13040357.","journal-title":"Cells"},{"key":"2512_CR58","doi-asserted-by":"publisher","first-page":"104457","DOI":"10.1016\/j.phrs.2019.104457","volume":"148","author":"L Tao","year":"2019","unstructured":"Tao, L., Y. Wang, J. Xu, J. Su, Q. Yang, and W. Deng et al. 2019. IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock. Pharmacological Research 148:104457.","journal-title":"Pharmacological Research"},{"issue":"5","key":"2512_CR59","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"R de Waal Malefyt","year":"1991","unstructured":"de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine 174 (5): 1209\u201320.","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"2512_CR60","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jimmunol\/197.5.1539","volume":"197","author":"DF Fiorentino","year":"2016","unstructured":"Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O\u2019Garra. 2016. Pillars article: IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991. 147: 3815\u20133822. Journal of Immunology (Baltimore, Md.\u202f: 1950) 197 (5): 1539\u201346.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"11","key":"2512_CR61","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1164\/rccm.200203-217OC","volume":"166","author":"T Fumeaux","year":"2002","unstructured":"Fumeaux, T., and J. Pugin. 2002. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. American Journal of Respiratory and Critical Care Medicine 166 (11): 1475\u20131482.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"2512_CR62","first-page":"161","volume":"11","author":"A Lekkou","year":"2004","unstructured":"Lekkou, A., M. Karakantza, A. Mouzaki, F. Kalfarentzos, and C.A. Gogos. 2004. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clinical and Diagnostic Laboratory Immunology 11 (1): 161\u2013167.","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"2","key":"2512_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.imlet.2004.07.009","volume":"95","author":"G Monneret","year":"2004","unstructured":"Monneret, G., M-E. Finck, F. Venet, A-L. Debard, J. Boh\u00e9, and J. Bienvenu et al. 2004. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunology Letters 95(2):193\u2013198.","journal-title":"Immunology Letters"},{"issue":"5","key":"2512_CR64","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/eji.1830270526","volume":"27","author":"T De Smedt","year":"1997","unstructured":"De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. European Journal of Immunology 27 (5): 1229\u201335.","journal-title":"European Journal of Immunology"},{"issue":"3","key":"2512_CR65","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","volume":"178","author":"A D'Andrea","year":"1993","unstructured":"D\u2019Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells. Journal of Experimental Medicine 178 (3): 1041\u20138.","journal-title":"Journal of Experimental Medicine"},{"issue":"10","key":"2512_CR66","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","volume":"159","author":"K Steinbrink","year":"1997","unstructured":"Steinbrink, K., M. W\u00f6lfl, H. Jonuleit, J. Knop, and A.H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. Journal of Immunology (Baltimore, Md.\u202f: 1950) 159 (10): 4772\u201380.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"5","key":"2512_CR67","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","volume":"93","author":"K Steinbrink","year":"1999","unstructured":"Steinbrink, K., H. Jonuleit, G. M\u00fcller, G. Schuler, J. Knop, and A.H. Enk. 1999. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93 (5): 1634\u201342.","journal-title":"Blood"},{"key":"2512_CR68","doi-asserted-by":"crossref","unstructured":"Smith, L. K., G. M. Boukhaled, S. A. Condotta, S. Mazouz, J. J. Guthmiller, and R. Vijay et al. 2018. Interleukin-10 directly inhibits CD8\u2009+\u2009T cell function by enhancing N-Glycan branching to decrease antigen sensitivity. Immunity ;48(2).","DOI":"10.1016\/j.immuni.2018.01.006"},{"issue":"6652","key":"2512_CR69","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux, H., A. O\u2019Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, et al. 1997. A CD4\u2009+\u2009T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (6652): 737\u201342.","journal-title":"Nature"},{"issue":"6","key":"2512_CR70","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","volume":"49","author":"MG Roncarolo","year":"2018","unstructured":"Roncarolo, M.G., S. Gregori, R. Bacchetta, M. Battaglia, and N. Gagliani. 2018. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49 (6): 1004\u201319.","journal-title":"Immunity"},{"issue":"23","key":"2512_CR71","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer, J.S., K. To, K.C. Chang, O. Takasu, D.F. Osborne, A.H. Walton, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306 (23): 2594\u2013605.","journal-title":"JAMA"},{"issue":"1","key":"2512_CR72","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41467-023-44178-y","volume":"15","author":"E Vergadi","year":"2024","unstructured":"Vergadi, E., O. Kolliniati, I. Lapi, E. Ieronymaki, K. Lyroni, and V. I. Alexaki et al. 2024. An IL-10\/DEL-1 axis supports granulopoiesis and survival from sepsis in early life. Nature Communications 15(1):680.","journal-title":"Nature Communications"},{"issue":"6337","key":"2512_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip, W. K. E., N. Hoshi, D. S. Shouval, S. Snapper, and R. Medzhitov. 2017. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356(6337):513\u2013519.","journal-title":"Science"},{"issue":"21","key":"2512_CR74","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13914","volume":"6","author":"S Hobbs","year":"2018","unstructured":"Hobbs, S., M. Reynoso, A.V. Geddis, A.Y. Mitrophanov, and R.W. Matheny. 2018. LPS-stimulated NF-\u03baB p65 dynamic response marks the initiation of TNF expression and transition to IL-10 expression in RAW 264.7 macrophages. Physiological Reports 6 (21): e13914.","journal-title":"Physiological Reports"},{"key":"2512_CR75","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3389\/fimmu.2019.01788","volume":"10","author":"O Ernst","year":"2019","unstructured":"Ernst, O., Y. Glucksam-Galnoy, B. Bhatta, M. Athamna, I. Ben-Dror, Y. Glick, et al. 2019. Exclusive temporal stimulation of IL-10 expression in LPS-stimulated mouse macrophages by cAMP inducers and type I interferons. Frontiers In Immunology 10: 1788.","journal-title":"Frontiers In Immunology"},{"issue":"12","key":"2512_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109728","volume":"36","author":"AF Alexander","year":"2021","unstructured":"Alexander, A.F., I. Kelsey, H. Forbes, and K. Miller-Jensen. 2021. Single-cell secretion analysis reveals a dual role for IL-10 in restraining and resolving the TLR4-induced inflammatory response. Cell Reports 36 (12): 109728.","journal-title":"Cell Reports"},{"issue":"1","key":"2512_CR77","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2020.07.089","volume":"530","author":"CB Bergmann","year":"2020","unstructured":"Bergmann, C.B., C.E. Salyer, N. Beckmann, and C.C. Caldwell. 2020. Intraperitoneal neutrophil IL-10 production is promoted by interferon \u03b3 in a murine model of sepsis model in the acute phase of sepsis. Biochemical and Biophysical Research Communications 530 (1): 278\u201384.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"45","key":"2512_CR78","doi-asserted-by":"publisher","first-page":"46818","DOI":"10.1074\/jbc.M401722200","volume":"279","author":"S-H Im","year":"2004","unstructured":"Im, S.-H., A. Hueber, S. Monticelli, K.-H. Kang, and A. Rao. 2004. Chromatin-level regulation of the IL10 gene in T cells. Journal of Biological Chemistry 279 (45): 46818\u201346825.","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"2512_CR79","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.4049\/jimmunol.175.11.7437","volume":"175","author":"EA Jones","year":"2005","unstructured":"Jones, E.A., and R.A. Flavell. 2005. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. Journal of Immunology (Baltimore, Md.\u202f: 1950) 175 (11): 7437\u201346.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2512_CR80","doi-asserted-by":"publisher","first-page":"101324","DOI":"10.1016\/j.smim.2019.101324","volume":"44","author":"H Zhang","year":"2019","unstructured":"Zhang, H., and V. Kuchroo. 2019. Epigenetic and transcriptional mechanisms for the regulation of IL-10. Seminars In Immunology 44:101324.","journal-title":"Seminars In Immunology"},{"key":"2512_CR81","first-page":"157","volume":"380","author":"L Gabry\u0161ov\u00e1","year":"2014","unstructured":"Gabry\u0161ov\u00e1, L., A. Howes, M. Saraiva, and A. O\u2019Garra. 2014. The regulation of IL-10 expression. Current Topics in Microbiology and Immunology 380: 157\u2013190.","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"9","key":"2512_CR82","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.1915","volume":"11","author":"R Gandhi","year":"2010","unstructured":"Gandhi, R., D. Kumar, E. J. Burns, M. Nadeau, B. Dake, and A. Laroni et al. 2010. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nature Immunology 11(9):846\u2013853.","journal-title":"Nature Immunology"},{"issue":"3","key":"2512_CR83","doi-asserted-by":"publisher","first-page":"112193","DOI":"10.1016\/j.celrep.2023.112193","volume":"42","author":"D Avancini","year":"2023","unstructured":"Avancini, D., A. Testori, L. Fresolone, G. Andolfi, M. Vuono, and V. Martinelli et al. 2023. Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells. Cell Rep 42(3):112193.","journal-title":"Cell Rep"},{"issue":"1","key":"2512_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez, C., and F.J. Quintana. 2018. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48 (1): 19\u201333.","journal-title":"Immunity"},{"key":"2512_CR85","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3389\/fimmu.2018.02033","volume":"9","author":"J Zhu","year":"2018","unstructured":"Zhu, J., L. Luo, L. Tian, S. Yin, X. Ma, S. Cheng, et al. 2018. Aryl hydrocarbon receptor promotes IL-10 expression in inflammatory macrophages through Src-STAT3 signaling pathway. Frontiers In Immunology 9: 2033.","journal-title":"Frontiers In Immunology"},{"key":"2512_CR86","doi-asserted-by":"crossref","unstructured":"Villagra, A., F. Cheng, H-W. Wang, I. Suarez, M. Glozak, and M. Maurin et al. 2008. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nature Immunology ;10(1).","DOI":"10.1038\/ni.1673"},{"issue":"33","key":"2512_CR87","doi-asserted-by":"publisher","first-page":"22980","DOI":"10.1074\/jbc.M114.573089","volume":"289","author":"MWM van den Bosch","year":"2014","unstructured":"van den Bosch, M.W.M., E. Palsson-Mcdermott, D.S. Johnson, and L.A.J. O\u2019Neill. 2014. LPS induces the degradation of programmed cell death protein 4 (PDCD4) to release Twist2, activating c-Maf transcription to promote interleukin-10 production. Journal of Biological Chemistry 289 (33): 22980\u201390.","journal-title":"Journal of Biological Chemistry"},{"key":"2512_CR88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.redox.2016.09.005","volume":"10","author":"WA Baseler","year":"2016","unstructured":"Baseler, W. A., L. C. Davies, L. Quigley, L. A. Ridnour, J. M. Weiss, and S. P. Hussain et al. 2016. Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production. Redox Biology 10:12\u201323.","journal-title":"Redox Biology"},{"issue":"6","key":"2512_CR89","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4049\/jimmunol.2001131","volume":"206","author":"IJ Jensen","year":"2021","unstructured":"Jensen, I.J., P.W. McGonagill, N.S. Butler, J.T. Harty, T.S. Griffith, and V.P. Badovinac. 2021. NK cell-derived IL-10 supports host survival during sepsis. Journal of Immunology (Baltimore, Md.\u202f: 1950) 206 (6): 1171\u201380.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"3","key":"2512_CR90","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.4049\/jimmunol.1500146","volume":"195","author":"DE Sanin","year":"2015","unstructured":"Sanin, D.E., C.T. Prendergast, and A.P. Mountford. 2015. IL-10 production in macrophages is regulated by a TLR-driven CREB-mediated mechanism that is linked to genes involved in cell metabolism. Journal of Immunology (Baltimore, Md.\u202f: 1950) 195 (3): 1218\u201332.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"2","key":"2512_CR91","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.4049\/jimmunol.177.2.1282","volume":"177","author":"X Zhang","year":"2006","unstructured":"Zhang, X., J.P. Edwards, and D.M. Mosser. 2006. Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. The Journal of Immunology 177 (2): 1282\u20131288.","journal-title":"The Journal of Immunology"},{"issue":"17","key":"2512_CR92","doi-asserted-by":"publisher","first-page":"11689","DOI":"10.1074\/jbc.M709657200","volume":"283","author":"G Stoecklin","year":"2008","unstructured":"Stoecklin, G., S. A. Tenenbaum, T. Mayo, S. V. Chittur, A. D. George, and T. E. Baroni et al. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. Journal Of Biological Chemistry 283(17):11689\u201311699.","journal-title":"Journal Of Biological Chemistry"},{"issue":"12","key":"2512_CR93","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.febslet.2011.05.029","volume":"585","author":"Y Liu","year":"2011","unstructured":"Liu, Y., Q. Chen, Y. Song, L. Lai, J. Wang, and H. Yu et al. 2011. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. Febs Letters 585(12):1963\u20131968.","journal-title":"Febs Letters"},{"key":"2512_CR94","first-page":"145","volume":"380","author":"SR Quinn","year":"2014","unstructured":"Quinn, S.R., and L.A. O\u2019Neill. 2014. The role of microRNAs in the control and mechanism of action of IL-10. Current Topics in Microbiology and Immunology 380: 145\u201355.","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"2512_CR95","doi-asserted-by":"publisher","first-page":"156006","DOI":"10.1016\/j.cyto.2022.156006","volume":"158","author":"AA Gharamti","year":"2022","unstructured":"Gharamti, A. A., O. Samara, A. Monzon, G. Montalbano, S. Scherger, and K. DeSanto et al. 2022. Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis. Cytokine 158:156006.","journal-title":"Cytokine"},{"issue":"1","key":"2512_CR96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/infdis\/171.1.229","volume":"171","author":"BHF Derkx","year":"1995","unstructured":"Derkx, B.H.F., A. Marchant, M. Goldman, R. Bijlmer, and S.JHv. Deventer. 1995. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. The Journal of Infectious Diseases 171 (1): 229\u201332.","journal-title":"The Journal of Infectious Diseases"},{"issue":"6","key":"2512_CR97","doi-asserted-by":"publisher","first-page":"e0179050","DOI":"10.1371\/journal.pone.0179050","volume":"12","author":"X Li","year":"2017","unstructured":"Li, X., Z. Xu, X. Pang, Y. Huang, B. Yang, and Y. Yang et al. 2017. Interleukin-10\/lymphocyte ratio predicts mortality in severe septic patients. PLoS One 12(6):e0179050.","journal-title":"PLoS One"},{"key":"2512_CR98","doi-asserted-by":"publisher","first-page":"1665915","DOI":"10.3389\/fmed.2025.1665915","volume":"12","author":"Y Yan","year":"2025","unstructured":"Yan, Y., X. Liu, X. Fu, J. Qin, F. He, and B. Liu et al. 2025. IL-10 to lymphocyte ratio (ILR) and lactate in the prognosis prediction and risk stratification of sepsis: a pilot study. Front Med (Lausanne) 12:1665915.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"2512_CR99","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","volume":"177","author":"S Yende","year":"2008","unstructured":"Yende, S., G. D\u2019Angelo, J. A. Kellum, L. Weissfeld, J. Fine, and R. D. Welch et al. 2008. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. American Journal Of Respiratory And Critical Care Medicine 177(11):1242\u20131247.","journal-title":"American Journal Of Respiratory And Critical Care Medicine"},{"issue":"10","key":"2512_CR100","first-page":"e70965","volume":"16","author":"V Reddy","year":"2024","unstructured":"Reddy, V., M. Wante, D.S. Nirhale, P. Puvvada, and R.H. Gaudani. 2024. The prospective analysis of biomarkers in sepsis: Correlation with clinical outcomes. Cureus 16 (10): e70965.","journal-title":"Cureus"},{"issue":"7","key":"2512_CR101","doi-asserted-by":"publisher","first-page":"e28681","DOI":"10.1097\/MD.0000000000028681","volume":"101","author":"M Xue","year":"2022","unstructured":"Xue, M., F. Xu, Y. Yang, Z. Tao, Y. Chen, and S. Wang et al. 2022. Diagnosis of sepsis with inflammatory biomarkers, cytokines, endothelial functional markers from SIRS patients. Medicine (Baltimore) 101(7):e28681.","journal-title":"Medicine (Baltimore)"},{"key":"2512_CR102","doi-asserted-by":"publisher","first-page":"923457","DOI":"10.3389\/fpubh.2022.923457","volume":"10","author":"W Zhang","year":"2022","unstructured":"Zhang, W., W. Wang, W. Hou, C. Jiang, J. Hu, and L. Sun et al. 2022. The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection. Front Public Health 10:923457.","journal-title":"Front Public Health"},{"key":"2512_CR103","doi-asserted-by":"crossref","unstructured":"Yang, X., J. Zeng, X. Yu, Z. Wang, D. Wang, and Q. Zhou et al. 2023. PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection. Ann Clin Microbiol Antimicrob. ;22(1):103.","DOI":"10.1186\/s12941-023-00653-4"},{"key":"2512_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1043968","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., B. Li, and B. Ning. 2022. Evaluating IL-6 and IL-10 as rapid diagnostic tools for Gram-negative bacteria and as disease severity predictors in pediatric sepsis patients in the intensive care unit. Frontiers in Immunology 13: 1043968.","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"2512_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24505","volume":"36","author":"G Zeng","year":"2022","unstructured":"Zeng, G., D. Chen, R. Zhou, X. Zhao, C. Ye, H. Tao, et al. 2022. Combination of C-reactive protein, procalcitonin, IL-6, IL-8, and IL-10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis. Journal of Clinical Laboratory Analysis 36 (7): e24505.","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"11","key":"2512_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105301","volume":"25","author":"Y Hong","year":"2022","unstructured":"Hong, Y., L. Chen, J. Sun, L. Xing, Y. Yang, X. Jin, et al. 2022. Single-cell transcriptome profiling reveals heterogeneous neutrophils with prognostic values in sepsis. iScience 25 (11): 105301.","journal-title":"iScience"},{"issue":"11","key":"2512_CR107","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L., A. Rhodes, W. Alhazzani, M. Antonelli, C. M. Coopersmith, and C. French et al. 2021. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine 49(11):e1063\u2013e143.","journal-title":"Critical Care Medicine"},{"issue":"8","key":"2512_CR108","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour, C. W., V. X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea, and A. Scherag et al. 2016. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal Of The American Medical Association 315(8):762\u2013774.","journal-title":"Journal Of The American Medical Association"},{"issue":"8","key":"2512_CR109","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.4049\/jimmunol.158.8.3971","volume":"158","author":"D Pajkrt","year":"1997","unstructured":"Pajkrt, D., L. Camoglio, M. C. Tiel-van Buul, K. de Bruin, D. L. Cutler, and M. B. Affrime et al. 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. The Journal Of Immunology 158(8):3971\u20133977.","journal-title":"The Journal Of Immunology"},{"issue":"5","key":"2512_CR110","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","volume":"165","author":"FN Lauw","year":"2000","unstructured":"Lauw, F.N., D. Pajkrt, C.E. Hack, M. Kurimoto, S.J. van Deventer, and T. van der Poll. 2000. Proinflammatory effects of IL-10 during human endotoxemia. Journal of Immunology (Baltimore, Md.\u202f: 1950) 165 (5): 2783\u20139.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"2","key":"2512_CR111","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/01.CCM.0000152229.69180.2","volume":"33","author":"A Kumar","year":"2005","unstructured":"Kumar, A., S. Zanotti, G. Bunnell, K. Habet, R. A\u00f1el, A. Neumann, et al. 2005. Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response. Critical Care Medicine 33 (2): 331\u201340.","journal-title":"Critical Care Medicine"},{"issue":"2","key":"2512_CR112","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0039-6060(99)70180-7","volume":"126","author":"GY Song","year":"1999","unstructured":"Song, G.Y., C.S. Chung, I.H. Chaudry, and A. Ayala. 1999. What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant? Surgery 126 (2): 378\u2013383.","journal-title":"Surgery"},{"issue":"8","key":"2512_CR113","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1128\/IAI.70.8.4441-4446.2002","volume":"70","author":"SQ Latifi","year":"2002","unstructured":"Latifi, S.Q., M.A. O\u2019Riordan, and A.D. Levine. 2002. Interleukin-10 controls the onset of irreversible septic shock. Infection and Immunity 70 (8): 4441\u20136.","journal-title":"Infection and Immunity"},{"key":"2512_CR114","doi-asserted-by":"crossref","unstructured":"Lyons, A., A. Goebel, J. A. Mannick, and J. A. Lederer. 1999. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Archives Of Surgery ;134(12).","DOI":"10.1001\/archsurg.134.12.1317"},{"key":"2512_CR115","doi-asserted-by":"crossref","unstructured":"Naing, A., J. R. Infante, K. P. Papadopoulos, I. H. Chan, C. Shen, and N. P. Ratti et al. 2018. PEGylated IL-10 (Pegilodecakin) Induces systemic immune activation, CD8\u2009+\u2009T cell invigoration and polyclonal T cell expansion in cancer patients. Cancer Cell ;34(5).","DOI":"10.1016\/j.ccell.2018.10.007"},{"issue":"29","key":"2512_CR116","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2016.68.1106","volume":"34","author":"A Naing","year":"2016","unstructured":"Naing, A., K. P. Papadopoulos, K. A. Autio, P. A. Ott, M. R. Patel, and D. J. Wong et al. 2016. Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. Journal Of Clinical Oncology 34(29):3562\u20133569.","journal-title":"Journal Of Clinical Oncology"},{"issue":"4","key":"2512_CR117","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/SHK.0b013e31815bbb26","volume":"29","author":"S Rajan","year":"2008","unstructured":"Rajan, S., D. Vyas, A. T. Clark, C. A. Woolsey, J. A. Clark, and R. S. Hotchkiss et al. 2008. Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis. Shock (Augusta, Ga.) 29(4):483\u2013489.","journal-title":"Shock (Augusta, Ga.)"},{"key":"2512_CR118","doi-asserted-by":"publisher","first-page":"118475","DOI":"10.1016\/j.biopha.2025.118475","volume":"191","author":"A Kunanopparat","year":"2025","unstructured":"Kunanopparat, A., W. Kaewduangduen, P. Chareanpat, A. Leelahavanichkul, A. Samaeng, and C. Chaiwichit et al. 2025. Immunomodulatory effects of phthiocol: An aryl hydrocarbon receptor ligand regulating conventional dendritic cells and macrophages to alleviate sepsis and lupus severity. Biomedicine & Pharmacotherapy 191:118475.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"2512_CR119","doi-asserted-by":"publisher","first-page":"eadu4034","DOI":"10.1126\/sciadv.adu4034","volume":"11","author":"RM Gallant","year":"2025","unstructured":"Gallant, R. M., K. K. Sanchez, E. Joulia, J. M. Snyder, C. M. Metallo, and J. S. Ayres. 2025. Fluoxetine promotes IL-10-dependent metabolic defenses to protect from sepsis-induced lethality. Science Advances 11(7):eadu4034.","journal-title":"Science Advances"},{"issue":"4","key":"2512_CR120","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport, E.E., K.L. Burnham, J. Radhakrishnan, P. Humburg, P. Hutton, T.C. Mills, et al. 2016. Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study. Lancet Respiratory Medicine 4 (4): 259\u201371.","journal-title":"Lancet Respiratory Medicine"},{"issue":"10","key":"2512_CR121","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna, B.P., L.A. van Vught, A.H. Zwinderman, M.A. Wiewel, E.E. Davenport, K.L. Burnham, et al. 2017. Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study. The Lancet Respiratory Medicine 5 (10): 816\u201326.","journal-title":"The Lancet Respiratory Medicine"},{"key":"2512_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-34","volume":"7","author":"HR Wong","year":"2009","unstructured":"Wong, H.R., N. Cvijanovich, R. Lin, G.L. Allen, N.J. Thomas, D.F. Willson, et al. 2009. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Medicine 7: 34.","journal-title":"BMC Medicine"},{"issue":"20","key":"2512_CR123","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour, C. W., J. N. Kennedy, S. Wang, C-CH Chang, C. F. Elliott, and Z. Xu et al. 2019. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. Journal Of The American Medical Association 321(20):2003\u20132017.","journal-title":"Journal Of The American Medical Association"},{"issue":"6","key":"2512_CR124","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","volume":"72","author":"LF Gentile","year":"2012","unstructured":"Gentile, L.F., A.G. Cuenca, P.A. Efron, D. Ang, A. Bihorac, B.A. McKinley, et al. 2012. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. Journal of Trauma and Acute Care Surgery 72 (6): 1491\u2013501.","journal-title":"Journal of Trauma and Acute Care Surgery"},{"issue":"3","key":"2512_CR125","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bja.2023.11.052","volume":"132","author":"KR Chadda","year":"2024","unstructured":"Chadda, K.R., and Z. Puthucheary. 2024. Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): A review of definitions, potential therapies, and research priorities. British Journal of Anaesthesia 132 (3): 507\u201318.","journal-title":"British Journal of Anaesthesia"},{"issue":"3","key":"2512_CR126","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1128\/IAI.69.3.1394-1401.2001","volume":"69","author":"RC Reddy","year":"2001","unstructured":"Reddy, R. C., G. H. Chen, M. W. Newstead, T. Moore, X. Zeng, and K. Tateda et al. 2001. Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10. Infection And Immunity 69(3):1394\u20131401.","journal-title":"Infection And Immunity"},{"issue":"2","key":"2512_CR127","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0760-z","volume":"21","author":"K Autio","year":"2019","unstructured":"Autio, K., and M. Oft. 2019. Pegylated interleukin-10: Clinical development of an immunoregulatory cytokine for use in cancer therapeutics. Current Oncology Reports 21 (2): 19.","journal-title":"Current Oncology Reports"},{"key":"2512_CR128","doi-asserted-by":"crossref","unstructured":"Francois, B., R. Jeannet, T. Daix, A. H. Walton, M. S. Shotwell, and J. Unsinger et al. 2018. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight ;3(5).","DOI":"10.1172\/jci.insight.98960"},{"issue":"5","key":"2512_CR129","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.4049\/jimmunol.1700127","volume":"199","author":"F Venet","year":"2017","unstructured":"Venet, F., J. Demaret, B. J. Blaise, C. Rouget, T. Girardot, and E. Idealisoa et al. 2017. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation. The Journal Of Immunology 199(5):1606\u20131615.","journal-title":"The Journal Of Immunology"},{"issue":"1","key":"2512_CR130","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","volume":"13","author":"T Daix","year":"2023","unstructured":"Daix, T., A. Mathonnet, S. Brakenridge, P.-F. Dequin, J.-P. Mira, F. Berbille, et al. 2023. Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: A double-blind, randomized, placebo-controlled trial. Annals of Intensive Care 13 (1): 17.","journal-title":"Annals of Intensive Care"},{"issue":"7","key":"2512_CR131","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel, C., J. C. Schefold, R. Pschowski, T. Baumann, K. Hetzger, and J. Gregor et al. 2009. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American Journal Of Respiratory And Critical Care Medicine 180(7):640\u2013648.","journal-title":"American Journal Of Respiratory And Critical Care Medicine"},{"key":"2512_CR132","doi-asserted-by":"publisher","first-page":"1130214","DOI":"10.3389\/fimmu.2023.1130214","volume":"14","author":"I Joshi","year":"2023","unstructured":"Joshi, I., W.P. Carney, and E.P. Rock. 2023. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Frontiers in Immunology 14: 1130214.","journal-title":"Frontiers in Immunology"},{"key":"2512_CR133","doi-asserted-by":"publisher","first-page":"154330","DOI":"10.1016\/j.jcrc.2023.154330","volume":"78","author":"C-H Vacheron","year":"2023","unstructured":"Vacheron, C.-H., A. Lepape, F. Venet, G. Monneret, F. Gueyffier, F. Boutitie, et al. 2023. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial. Journal of Critical Care 78: 154330.","journal-title":"Journal of Critical Care"},{"issue":"10","key":"2512_CR134","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-019-05704-z","volume":"45","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss, R.S., E. Colston, S. Yende, E.D. Crouser, G.S. Martin, T. Albertson, et al. 2019. Immune checkpoint inhibition in sepsis: A phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Medicine 45 (10): 1360\u201371.","journal-title":"Intensive Care Medicine"},{"issue":"5","key":"2512_CR135","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","volume":"47","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss, R. S., E. Colston, S. Yende, D. C. Angus, L. L. Moldawer, and E. D. Crouser et al. 2019. Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559). Critical Care Medicine 47(5):632\u2013642.","journal-title":"Critical Care Medicine"},{"key":"2512_CR136","doi-asserted-by":"publisher","first-page":"1323797","DOI":"10.3389\/fimmu.2023.1323797","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen, Y., D-Z. Guo, C-L. Zhu, S-C. Ren, C-Y. Sun, and Y. Wang et al. 2023. The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways. Frontiers In Immunology 14:1323797.","journal-title":"Frontiers In Immunology"},{"issue":"1","key":"2512_CR137","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1038\/s41467-025-57706-9","volume":"16","author":"M Gossez","year":"2025","unstructured":"Gossez, M., C. Vigneron, A. Vandermoeten, M. Lepage, L. Courcol, and R. Coudereau et al. 2025. PD-L1\u2009+\u2009plasma cells suppress T lymphocyte responses in patients with sepsis and mouse sepsis models. Nature Communications 16(1):3030.","journal-title":"Nature Communications"},{"issue":"1","key":"2512_CR138","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10753-023-01897-0","volume":"47","author":"L Yang","year":"2023","unstructured":"Yang, L., Q. Gao, Q. Li, and S. Guo. 2023. PD-L1 blockade improves survival in sepsis by reversing monocyte dysfunction and immune disorder. Inflammation 47 (1): 114\u2013128.","journal-title":"Inflammation"},{"key":"2512_CR139","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3182ab1ab5","author":"EL Vanzant","year":"2014","unstructured":"Vanzant, E.L., C.M. Lopez, T. Ozrazgat-Baslanti, R. Ungaro, R. Davis, A.G. Cuenca, et al. 2014. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. Journal of Trauma and Acute Care Surgery. https:\/\/doi.org\/10.1097\/TA.0b013e3182ab1ab5.","journal-title":"Journal of Trauma and Acute Care Surgery"},{"issue":"12","key":"2512_CR140","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cmi.2018.03.011","volume":"24","author":"J Rello","year":"2018","unstructured":"Rello, J., T.S.R. van Engelen, E. Alp, T. Calandra, V. Cattoir, W.V. Kern, et al. 2018. Towards precision medicine in sepsis: A position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clinical Microbiology and Infection 24 (12): 1264\u201372.","journal-title":"Clinical Microbiology and Infection"},{"issue":"4","key":"2512_CR141","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810128","volume":"12","author":"J-M Cavaillon","year":"2020","unstructured":"Cavaillon, J.-M., M. Singer, and T. Skirecki. 2020. Sepsis therapies: Learning from 30 years of failure of translational research to propose new leads. EMBO Molecular Medicine 12 (4): e10128.","journal-title":"EMBO Molecular Medicine"},{"issue":"2","key":"2512_CR142","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm.201604-0697ED","volume":"194","author":"CS Calfee","year":"2016","unstructured":"Calfee, C.S. 2016. Opening the debate on the new sepsis definition. Precision medicine: An opportunity to improve outcomes of patients with sepsis. American Journal of Respiratory and Critical Care Medicine 194 (2): 137\u20139.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"2512_CR143","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","volume":"46","author":"TE Sweeney","year":"2018","unstructured":"Sweeney, T. E., T. D. Azad, M. Donato, W. A. Haynes, T. M. Perumal, and R. Henao et al. 2018. Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters. Critical Care Medicine 46(6):915\u2013925.","journal-title":"Critical Care Medicine"},{"issue":"12","key":"2512_CR144","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","volume":"31","author":"AR Moore","year":"2025","unstructured":"Moore, A. R., H. Zheng, A. Ganesan, Y. Hasin-Brumshtein, M. V. Maddali, and J. E. Levitt et al. 2025. A consensus immune dysregulation framework for sepsis and critical illnesses. Nature Medicine 31(12):4084\u20134096.","journal-title":"Nature Medicine"},{"key":"2512_CR145","doi-asserted-by":"publisher","first-page":"104394","DOI":"10.1016\/j.ebiom.2022.104394","volume":"86","author":"M Komorowski","year":"2022","unstructured":"Komorowski, M., A. Green, K. C. Tatham, C. Seymour, and D. Antcliffe. 2022. Sepsis biomarkers and diagnostic tools with a focus on machine learning. EBioMedicine 86:104394.","journal-title":"EBioMedicine"},{"issue":"11","key":"2512_CR146","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis, K., E. Kyriazopoulou, N. Antonakos, A. Kotsaki, I. Tsangaris, and D. Markopoulou et al. 2022. Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. Cell Rep Med 3(11):100817.","journal-title":"Cell Rep Med"},{"key":"2512_CR147","unstructured":"Giamarellos-Bourboulis, E. J., A. Kotsaki, I. Kotsamidi, A. Efthymiou, V. Koutsoukou, and J. Ehler et al. 2025. Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial. Journal Of The American Medical Association"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02512-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02512-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02512-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:52:40Z","timestamp":1780631560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02512-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":147,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02512-8","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"During the process of writing this work, the author used deepseek and chatGPT to polish the article. After using these tools\/services, the author conducted necessary reviews and edits on the content and assumes full responsibility for the published article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI Usage Statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"147"}}